Ensoma acquiring Twelve Bio
Ensoma is acquiring core portfolio company Twelve Bio in an all-share transaction in connection with an $85 million financing of Ensoma.
Source: labiotech.eu
📰 Arix Bioscience News
Page 11 - Arix Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Arix Bioscience. Real-time updates on events, politics, business and more.
Arix Bioscience PLC: Portfolio company Twelve Bio to be acquired alongside USD85 million financing of Ensoma
DJ Portfolio company Twelve Bio to be acquired alongside USD85 million financing of Ensoma Arix Bioscience PLC (ARIX) Portfolio company Twelve Bio to be acquired alongside USD85 million financing
Source: finanznachrichten.de
Investegate |Arix Bioscience PLC Announcements | Arix Bioscience PLC: Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma
Investegate announcements from Arix Bioscience PLC, Portfolio company Twelve Bio to be acquired alongside $85 million financing of Ensoma
Source: investegate.co.uk
Investegate |Arix Bioscience PLC Announcements | Arix Bioscience PLC: Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
Investegate announcements from Arix Bioscience PLC, Portfolio Company Disc Medicine Completes Merger with Gemini Therapeutics
Source: investegate.co.uk
Disc Medicine Announces Completion of Merger with Gemini
The combined company will operate as Disc Medicine and will trade on the Nasdaq Global Market under the ticker symbol “IRON”Approximately $175 million of...
Wedbush Pacgrow Wilmer Cutler Pickering Hale Arix Bioscience John Quisel Morgan Stanley Disc Medicine Inc
Source: globenewswire.com
Arix Bioscience PLC: Unaudited NAV for October 2022
DJ Unaudited NAV for October 2022 Arix Bioscience PLC (ARIX) Unaudited NAV for October 2022 09-Nov-2022 / 07:00 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer
Source: finanznachrichten.de
Arix Bioscience PLC: Holding(s) in Company
DJ Holding(s) in Company Arix Bioscience PLC (ARIX) Holding(s) in Company 20-Oct-2022 / 16:30 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible
Source: finanznachrichten.de
Investegate |Arix Bioscience PLC Announcements | Arix Bioscience PLC: Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics
Investegate announcements from Arix Bioscience PLC, Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics
Source: investegate.co.uk
Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics
Arix Bioscience PLC (ARIX) Portfolio Company Imara Announces Merger Agreement with Enliven Therapeutics 14-Oct-2022 / 07:00 GMT/BST D...
City Of United Kingdom Robert Lyne Arix Bioscience Enliven Therapeutics Inc Fidelity Management Research Company
Source: businessinsider.com
Pharma Cos. Imara And Enliven Therapeutics Agree To Merger
Arix Bioscience PLC subsidiary Imara Inc. and Enliven Therapeutics Inc. said on Friday they have agreed to merge in an all-stock deal to create a pharmaceutical company valued at approximately $300 million, according to a London Stock Exchange announcement.
Source: law360.com